iShares U.S. Pharmaceuticals ETF (IHE)
IHE is a passive ETF by iShares tracking the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. IHE launched on May 5, 2006 and has a 0.42% expense ratio.
ETF Info
ISIN | US4642888360 |
---|---|
CUSIP | 464288836 |
Issuer | iShares |
Inception Date | May 5, 2006 |
Region | North America (U.S.) |
Category | Health & Biotech Equities |
Index Tracked | Dow Jones U.S. Select Pharmaceuticals Index |
Home Page | www.ishares.com |
Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
The iShares U.S. Pharmaceuticals ETF has a high expense ratio of 0.42%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: IHE vs. PPH, IHE vs. IAK, IHE vs. XLV, IHE vs. PJP, IHE vs. XPH, IHE vs. NOBL, IHE vs. BBP, IHE vs. VYM, IHE vs. FXAIX, IHE vs. QQQ
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in iShares U.S. Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
iShares U.S. Pharmaceuticals ETF had a return of 2.86% year-to-date (YTD) and 9.40% in the last 12 months. Over the past 10 years, iShares U.S. Pharmaceuticals ETF had an annualized return of 8.63%, while the S&P 500 had an annualized return of 10.52%, indicating that iShares U.S. Pharmaceuticals ETF did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 2.86% | 6.92% |
1 month | -6.48% | -2.83% |
6 months | 15.22% | 23.86% |
1 year | 9.40% | 23.33% |
5 years (annualized) | 9.97% | 11.66% |
10 years (annualized) | 8.63% | 10.52% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 2.95% | 6.67% | 0.45% | |||||||||
2023 | -5.29% | -5.38% | 4.78% | 6.37% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
iShares U.S. Pharmaceuticals ETF(IHE)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
iShares U.S. Pharmaceuticals ETF granted a 3.43% dividend yield in the last twelve months. The annual payout for that period amounted to $2.17 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | $2.17 | $2.57 | $3.73 | $2.98 | $2.14 | $2.24 | $1.77 | $2.10 | $1.30 | $3.11 | $1.82 | $1.25 |
Dividend yield | 3.43% | 4.16% | 6.02% | 4.48% | 3.57% | 4.19% | 3.76% | 4.08% | 2.75% | 5.78% | 3.60% | 3.19% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares U.S. Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.00 | $0.28 | |||||||||
2023 | $0.00 | $0.00 | $0.67 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.90 | $0.00 | $0.00 | $0.40 |
2022 | $0.00 | $0.00 | $0.79 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.89 | $0.00 | $0.00 | $1.34 |
2021 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.83 | $0.00 | $0.00 | $0.79 |
2020 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.53 |
2019 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.52 |
2018 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.35 |
2017 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.92 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.37 |
2016 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.34 |
2015 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $2.09 |
2014 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 |
2013 | $0.30 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.34 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares U.S. Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares U.S. Pharmaceuticals ETF was 35.30%, occurring on Mar 5, 2009. Recovery took 143 trading sessions.
The current iShares U.S. Pharmaceuticals ETF drawdown is 8.60%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-35.3% | May 23, 2007 | 450 | Mar 5, 2009 | 143 | Sep 28, 2009 | 593 |
-29.17% | Jan 17, 2020 | 45 | Mar 23, 2020 | 94 | Aug 5, 2020 | 139 |
-25.13% | Jul 17, 2015 | 145 | Feb 11, 2016 | 493 | Jan 26, 2018 | 638 |
-21.03% | Sep 4, 2018 | 78 | Dec 24, 2018 | 250 | Dec 20, 2019 | 328 |
-16.88% | Jul 8, 2011 | 22 | Aug 8, 2011 | 84 | Dec 6, 2011 | 106 |
Volatility
Volatility Chart
The current iShares U.S. Pharmaceuticals ETF volatility is 3.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.